布地奈德干预治疗重度新生儿急性呼吸窘迫综合征的临床分析

doi:10.3969/j.issn.2095-5340.2020.01.009

发育医学电子杂志

2020, Vol. 8

Issue (1): 47-52 DOI: 10.3969/j.issn.2095-5340.2020.01.009

围产医学论著｜新生儿

布地奈德干预治疗重度新生儿急性呼吸窘迫综合征的临床分析

尹晓娟　张宣　陈佳　池婧涵　韩涛　赵丹华　贺艳梅　封志纯

1. 解放军总医院海南分院　儿科，海南　100191；2. 解放军总医院第七医学中心八一儿童医院　新生儿重症监护病房，北京　100700

Clinical analysis of budesonide intervention in the treatment of severe neonatal acute respiratory distress syndrome

YIN Xiao-juan, ZHANG Xuan, CHEN Jia,et al

1. Pediatrics, Hainan Hospital of PLA Genenal Hospital, Hainan 100191, China;2. Neonatal Intensive Care Unit of Bayi Children's Hospital, Seventh Medical Center of PLA General Hospital, Beijing 100700, China

摘要
相关文章
推荐阅读
Metrics

下载:

PDF (974KB)
输出: BibTeX | EndNote (RIS)

摘要 【摘要】目的　探讨布地奈德对重度新生儿急性呼吸窘迫综合征（neonatal acute respiratory distress syndrome，NARDS）的治疗效应。方法　选择2017 年12 月31 日至2019 年11 月30 日在解放军总医院第七医学中心八一儿童医院NICU 住院的70 例重度NARDS 为研究对象，随机分为干预组和对照组，每组35 例。干预组经气管插管导管内滴入布地奈德，每次0.5 mg/kg，每8 小时一次，连用2 d ；对照组以同样方式给予相同体积的生理盐水。收集两组患儿的围产期孕母资料、新生儿资料和血气分析指标等。采用两独立样本t 检验、χ² 检验或Fisher 精确概率法进行统计学分析。结果　两组围产期孕母资料比较，差异无统计学意义（P>0.05）。干预组HFOV 使用的比例（74.3%）高于对照组（51.4%）（ χ²= 3.916，P<0.05）。干预组使用肺表面活性物质的比例（45.7%）低于对照组（71.4%）（χ²=4.769，P<0.05）) ；干预组气漏发生的比例（2.9%）低于对照组（20.0%）（P<0.05）；干预组气道高反应性（咳嗽）发生的比例（14.3%）低于对照组（48.6%）（ χ²= 9.545，P<0.05）。两组间的住院时间、死亡和体外膜肺氧合（ECMO）治疗的比例差异无统计学意义（P 值均>0.05）；两组间高血压、水肿、低钾血症、高钠血症发生的比例比较差异无统计学意义（P 值均>0.05）。干预组与对照组比较，治疗前和治疗后7 d 两组的二氧化碳分压（PaCO₂）、氧分压（PaO₂）和氧合指数（OI），3 项指标差异均无统计学意义（P 值均>0.05）。结论　布地奈德能减少气漏、阻止或减轻气道高反应性的发生，对NARDS 具有治疗效应。

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词: 新生儿')" href="#">新生儿急性呼吸窘迫综合征布地奈德气漏肺表面活性物质

Abstract: 【Abstract】 Objective　To investigate the therapeutic effect of budesonide on severe neonatal acute respiratory distress syndrome (NARDS). Methods　In the neonatal intensive care unit (NICU) of Bayi Children's Hospital, Seventh Medical Center of PLA General Hospital, 70 cases with severe NARDS were recruited from December 31, 2017 to November 30, 2019 and randomly divided into two groups, 35 cases in the intervention group and 35 cases in the control group. In the intervention group, budesonide was used with intratracheal instillation, 0.5 mg/kg per time, once per 8 hours, for 2 days; the control group was
given the same volume of saline in the same way. Perinatal pregnancy maternal, neonatal clinical data andblood gas analysis indicators of the two groups were collected and analyzed. The statistical analysis was carried out by t test, χ² test or Fisher's exact test. Results　There was no significant difference in perinatal maternal data between the two groups (P>0.05). The ratio of HFOV used in the intervention group (74.3%) was higher than that in the control group (51.4%) (χ²=3.916, P<0.05) , while the ratio of pulmonary surfactant used in the intervention group (45.7%) was lower than that in the control group (71.4%) (χ²=4.769,P<0.05) . The ratio of air leakage in the intervention group (2.9%) was lower than that in the control group
(20.0%) (P<0.05). The ratio of airway hyperresponsiveness (cough) in the intervention group (14.3%) was lower than that in the control group (48.6%) (χ²=9.545, P<0.05). There was no statistical significance in the length of hospitalization, death, and ECMO treatment between the two groups (all P>0.05); there was no statistical significance in the ratio of hypertension, edema, hypokalemia, and hypernatremia between the two groups (all P> 0.05). There was also no statistical significance in PaCO₂, PaO₂ and OI before and 7 days after treatment between the two groups (P>0.05). Conclusion Budesonide can reduce air leakage,
prevent or alleviate airway hyperresponsiveness, and has therapeutic effect on NARDS.

Key words: Neonatal')" href="#">Neonatal Acute respiratory distress syndrome Budesonide Air leakage surfactant')" href="#">Pulmonary surfactant

收稿日期: 2019-12-16 出版日期: 2020-01-30 发布日期: 2020-01-22 期的出版日期: 2020-01-30

基金资助: 国家自然科学基金（30871397）

通讯作者: 封志纯https://baike.baidu.com/item/%E5%B0%81%E5%BF%97%E7%BA%AF/9328206?fr=aladdin E-mail: zhjfengzc@126.com

引用本文:

尹晓娟　张宣　陈佳　池婧涵　韩涛　赵丹华　贺艳梅　封志纯. 布地奈德干预治疗重度新生儿急性呼吸窘迫综合征的临床分析[J]. 发育医学电子杂志, 2020, 8(1): 47-52.
YIN Xiao-juan, ZHANG Xuan, CHEN Jia, et al. Clinical analysis of budesonide intervention in the treatment of severe neonatal acute respiratory distress syndrome. Journal of Developmental Medicine(Electronic Version), 2020, 8(1): 47-52.

链接本文:

http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2020.01.009 或 http://www.fyyxzz.com/CN/Y2020/V8/I1/47

[1]	朱小瑜　吴本清　杨传忠. 新生儿复苏有关基础概念的溯源和厘清 [J]. 发育医学电子杂志, 2020, 8(4): 304-307.
[2]	李婷　彭薇　马宁　李昊　杨晓. 遗传性耳聋基因芯片在新生儿重症监护室筛查中的应用 [J]. 发育医学电子杂志, 2020, 8(4): 338-341.
[3]	朱恋　马娟　朱丹　刘慧. 新生儿枫糖尿症合并生殖器畸形 1 例 [J]. 发育医学电子杂志, 2020, 8(4): 358-358，377.
[4]	王英杰　毛健. 新生儿缺氧缺血性脑病脑电图监测关键问题研究进展 [J]. 发育医学电子杂志, 2020, 8(4): 359-364.
[5]	胡媛　史源. 新生儿胆红素脑损伤的研究进展 [J]. 发育医学电子杂志, 2020, 8(4): 365-369.
[6]	姚恩凤　陈中举　陈玲. 新生儿败血症病原菌分布及药敏分析 [J]. 发育医学电子杂志, 2020, 8(3): 239-245.
[7]	封志纯. 抓紧补好新生儿科肠道病毒医院感染防控的功课[J]. 发育医学电子杂志, 2020, 8(2): 97-98.
[8]	杨晓　彭薇　马宁　李昊　张艳平. 西北地区751 例新生儿耳聋基因突变筛查[J]. 发育医学电子杂志, 2020, 8(2): 140-144.
[9]	朱晶文　张雪峰. 新生儿出生后24 小时内凝血功能检测的临床意义分析[J]. 发育医学电子杂志, 2020, 8(2): 157-162.
[10]	李书芳　张艳　李艳民　魏燕云　孙园园　郭志灵. 新生儿脐静脉置管核查表单在降低导管相关血流感染率中的作用[J]. 发育医学电子杂志, 2020, 8(1): 67-71.
[11]	孙萌　李育霖　邹卉. 新生儿期异戊酸血症3 例诊治与随访[J]. 发育医学电子杂志, 2020, 8(1): 77-80.
[12]	邱如新　刘敬. 胎盘早剥与新生儿弥散性血管内凝血[J]. 发育医学电子杂志, 2019, 7(3): 178-181.
[13]	叶环饶燕晓徐琛俞栋阮欢. 住院新生儿乳糖酶缺乏及其体格生长的随访研究[J]. 发育医学电子杂志, 2019, 7(2): 115-120.
[14]	王钰　许平. 新生儿红斑狼疮 1 例[J]. 发育医学电子杂志, 2018, 6(3): 190-192.
[15]	郭果　祁娇　郭玉婷　张雪峰. 窒息复苏后新生儿动脉血气分析对窒息的评估意义[J]. 发育医学电子杂志, 2018, 6(3): 172-175.

[1]	GAO Xiao-hui, MAO Jian. Clinical features of non-oliguric hyperkalemia in extremely low birth weight infants[J]. Journal of Developmental Medicine(Electronic Version), 0, (): 152 .
[2]	Society of Neonatologist, Chinese Medical Doctor Association. Consensus recommendations on the prevention and early management of respiratory distress syndrome in preterm infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 129 -131 .
[3]	Professional Committee of Respiratory, Society of Neonatologist, Chinese Medical Doctor Association. Clinical application recommendations for heated humidified high flow nasal cannula[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 132 -135 .
[4]	YAN Jun, ZHU Xing-wang, SHI Yuan. Application progress of noninvasive ventilate technique for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 136 -140 .
[5]	GU Min-fang, YANG Chuan-zhong. Progress of intrapartum resuscitation for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 141 -145 .
[6]	LIU Shu-hua, SHEN Yue-bo, LIU Cui-qing, MA Li. The efficacy of pulmonary surfactant for pulmonary function in premature tension pneumothorax[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 146 -151 .
[7]	GAO Xiao-hui, MAO Jian. Clinical features of non-oliguric hyperkalemia in extremely low birth weight infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 152 -158 .
[8]	XIA Yao-fang, YANG Juan , TIAN Bao-li, et al. Value of amplitude-integrated electroencephalography in monitoring acute period of neonatal bilirubin encephalopathy and prognostic assessment[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 159 -163 .
[9]	WANG Li-rong, SUN Xiao-yan, ZHU Ruo-xin, et al. Epidemiological investigation and analysis of women aged 40-55 years old with osteoporosis in Gansu province[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 164 -167 .
[10]	CHEN Ru-yue, SHEN Yun-yan, CHEN Qing , et al. Five cases about Henoch-Schönlein purpura complicated with central nervous system injury in children and literatures review[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 168 -171 .

Viewed

Full text

Abstract

Cited

Shared

Discussed